Sequential Medicine Ltd
Quick facts
Marketed products
- D+L · Nutritional/Wellness
D+L is a combination of vitamin D and L-theanine designed to support immune function and promote relaxation. - D+Z · Virology / Hepatology
D+Z is a fixed-dose combination of daclatasvir and sofosbuvir that inhibits hepatitis C virus NS5A and NS5B proteins to block viral replication.
Phase 3 pipeline
- SM-1 · Oncology
SM-1 is a small molecule that targets the PD-1 receptor.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: